Travel, heterosexual intercourse and HIV-1 infection. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Travel, heterosexual intercourse and HIV-1 infection.

CDR (Lond Engl Rev). 1991 Mar 29;1(4):R39-43. Unique Identifier : AIDSLINE MED/94138446
Noone A; Gill ON; Clarke SE; Porter K

Abstract: One hundred and seventy AIDS cases and 547 HIV-1 antibody positive reports of infection in persons who are presumed to have become infected by sexual intercourse between men and women abroad are reviewed. Eighty three percent of people with AIDS and 99% of HIV-1 infected persons were reported to have been exposed in countries where heterosexual spread of HIV infection is well documented (i.e. WHO patterns II or I/II - see below). African countries were commonly cited. The group that had been exposed heterosexually in pattern II or I/II countries was young, and males slightly outnumbered females. Persons who are presumed to have become infected with HIV-1 through heterosexual contact abroad make up a heterogeneous group of travellers which includes holiday makers, business persons, students, refugees and immigrants. Research is needed to identify travellers whose high risk behaviour makes them vulnerable to HIV-1 infection, and to develop effective health education measures for them.
Keywords: Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY/PREVENTION & CONTROL/*TRANSMISSION Adult England/EPIDEMIOLOGY Female Human HIV Infections/EPIDEMIOLOGY/PREVENTION & CONTROL/*TRANSMISSION HIV Seroprevalence/*TRENDS *HIV-1 Male Risk Factors *Sex Behavior *Travel Wales/EPIDEMIOLOGY JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/epidemiology/prevention&control/KWDtransmissionadultengland/epidemiologyfemalehumanhivinfections/epidemiology/prevention&control/KWDtransmissionhivseroprevalence/KWDtrendsKWDhiv-1maleriskfactorsKWDsexbehaviorKWDtravelwales/epidemiologyjournalarticle
940530
M9450874

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .